Recurring Revenue Is an Asset: How to Value Your Med Spa Membership Base

A med spa marketing lead posted their own numbers on r/medspa almost as an aside: the membership program had passed 1,175 members and was producing roughly $203,000 a month in recurring revenue. The post scored two points and drew five comments. Nobody treated it as remarkable. I logged it during a research pass in June 2026 and did not keep the permalink, so treat those two figures as one operator's unverified self-report. I kept the note anyway, because the people who buy these businesses for a living have done the same arithmetic in public. A recurring-revenue base is the closest thing an aesthetics practice has to a contracted asset, and most owners carry it on the books as a discount program they run out of habit. Here is what that base is worth in a buyer's model, why churn quietly halves it, and why it is a retention engine rather than a coupon.

What a recurring membership base is actually worth

Start with the people who price these businesses, because they have already done the valuation work you have not. CT Acquisitions' Med Spa and Medical Aesthetic M&A Multiples Report 2026, published July 1, 2026, reports that membership revenue share is now the single strongest observable driver of multiple expansion in the segment. The specific number comes from FOCUS Investment Banking's 2026 Medspa Valuation Multiples Dashboard, cited in that report: a practice with 30 to 40 percent of revenue from memberships adds 0.5x to 1.0x turns to the multiple of an otherwise identical non-membership peer.

Run that against your own statements. On a practice doing $1 million of adjusted EBITDA, that premium is $500,000 to $1 million of enterprise value produced by revenue mix alone, with no new device and no new provider. Same practice, priced differently, because a portion of the earnings arrives on a schedule instead of arriving by persuasion.

The detail that should get your attention is what buyers do with that belief at the closing table. The same report calls membership-retention earnouts the fastest-growing structural feature of 2025 to 2026 med spa transactions, typically putting 10 to 25 percent of enterprise value at risk against trailing membership retention. Read that plainly: a buyer will hold back a fifth of your price and pay it only if the members stay. They are not treating your membership base as a marketing program. They are treating it as the collateral.

You cannot defend in diligence an asset you have never valued. Write the number down: active members, monthly recurring revenue, and annual run rate, on one line, updated monthly.

Why churn quietly erodes the base

Two forces work against that asset, and both are silent.

The first is churn, and this is where I want to correct a habit I see in a lot of practice advice, including some of my own earlier framing. There is no secret threshold above which a membership program is broken. CT Acquisitions reports that buyers underwrite these bases with retention math borrowed from software: monthly churn of 5 to 10 percent produces a member lifetime of roughly 10 to 20 months. That band is the normal range for the industry, not a warning sign.

The warning sign is not knowing where in that band you sit, because the band is not narrow. The arithmetic is one division: average member lifetime in months is one divided by your monthly churn rate. At 5 percent the average member stays about 20 months, at 10 percent about 10 months. Same program, same price sheet, and one of those practices owns twice the asset the other does. Nobody notices month to month, because new sign-ups paper over the losses at the top of the bucket while the bottom drains. If you track net member count instead of gross monthly churn, you are watching the one number that hides the leak.

The second force is underpricing, and here I am giving you my read rather than a sourced finding: I have not found a credible published dataset on membership contribution margin by tier in aesthetics, and I would discount one a software vendor published about its own customers. My read is that owners set a membership price to feel like a discount, then never revisit it while injectable and product costs climb. A tier priced three or four years ago can be underwater today, subsidizing the exact patients least likely to leave. Your most loyal patients are the least price sensitive you have, and they hold your deepest standing discount. That is backwards, and you can confirm or refute it on your own numbers this week rather than taking my word for it.

A membership is a retention engine, not a discount club

Here is the reframe that changes how you run the program. Membership is not a pricing gimmick. It is the most reliable retention instrument you own, and the market data now says retention is where the growth is.

Zenoti's 2025 Beauty and Wellness Benchmark Report, drawn from its base of more than 30,000 businesses, found that new guest visits fell 9 percent industry wide in 2024. In the same year, membership sales grew 24 percent across salons, waxing centers, and medspas. Acquisition contracted and pre-committed revenue expanded, in the same market, in the same twelve months. The same report puts rebooking at 69 percent for top-earning medspas against 40 percent for the average, and top-earning membership-based spas at $2.49 million of annual revenue per location against $2.1 million for top-earning non-membership spas.

On individual member behavior, the honest answer is that the good figures are vendor reported. CT Acquisitions cites operational data from MyTime, ProSpyr, and Portrait Care putting member visit frequency at 2.9 times that of non-members and member annual spend 35 percent above non-members. Treat those as directional, not as a benchmark you can defend in a negotiation. The direction is not in dispute across any of these sources: a patient who has pre-committed to a cadence is worth a multiple of one who has not.

That is why the membership base deserves more attention than the next ad campaign, not less. Acquisition buys you a stranger who might convert, in a market where new guest visits are declining. Retention compounds a relationship you already paid to start. When an owner tells me the growth plan is entirely new-patient acquisition, I know where the cheapest revenue in the building is sitting.

The Strategic Recommendation

In the next 30 days, before you approve another acquisition budget, build a one-page membership P&L and read it every month.

Five lines, no more. Active members. Monthly recurring revenue. Gross monthly churn as its own percentage, never netted against sign-ups. Average member tenure in months. Contribution margin per tier after product and provider cost.

Then act on what it shows, in this order. Divide one by your monthly churn rate and compare the result against the 10 to 20 month band buyers underwrite. If you land near 10, retention is the priority and acquisition can wait a quarter, because you are replacing the base almost as fast as you build it. If any tier's contribution margin has gone negative, reprice it at renewal within the quarter. If tenure is short but churn is concentrated in the first three months, the leak is in how you onboard new members, not in the price.

You will not fix all three at once. Rank them by dollars at stake and take the largest first. Within 90 days you are managing a valued asset on real numbers instead of running a discount program on faith, and you can answer the retention question before a buyer or a lender asks it.

Where GrowBien fits

The reason this asset goes unmanaged is not that owners do not care. It is that the numbers live in the booking system, the payment processor, and the owner's memory, and nobody assembles them onto a single line each month. Pulling that membership P&L together automatically, including the gross churn figure that converts into an average member lifetime of 10 to 20 months, is on the GrowBien product roadmap rather than something we ship today. In the meantime the five lines above take an afternoon in a spreadsheet and are worth more than the next campaign. If you want a second pair of eyes on where your growth is actually coming from, book a free marketing review.

Sources: CT Acquisitions, Med Spa and Medical Aesthetic M&A Multiples Report 2026 (July 1, 2026), which also carries the cited FOCUS Investment Banking 2026 Medspa Valuation Multiples Dashboard figures; Zenoti, 2025 Beauty and Wellness Benchmark Report.